These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35301852)

  • 1. Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population-Based Cohort Study.
    Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Salahudeen MS; Garrahy E; Bindoff I; Peterson GM
    J Am Heart Assoc; 2022 Apr; 11(7):e023098. PubMed ID: 35301852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation.
    Kim D; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
    Europace; 2021 Feb; 23(2):184-195. PubMed ID: 33063123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study.
    Mitchell A; Snowball J; Welsh TJ; Watson MC; McGrogan A
    BMC Med; 2021 Aug; 19(1):189. PubMed ID: 34461899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study.
    Søgaard M; Skjøth F; Jensen M; Kjældgaard JN; Lip GYH; Larsen TB; Nielsen PB
    J Am Heart Assoc; 2019 Jun; 8(11):e011358. PubMed ID: 31138001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
    Martinez BK; Sood NA; Bunz TJ; Coleman CI
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
    Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
    Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation.
    Chen N; Lutsey PL; MacLehose RF; Claxton JS; Norby FL; Chamberlain AM; Bengtson LGS; O'Neal WT; Chen LY; Alonso A
    J Am Heart Assoc; 2018 Nov; 7(21):e009561. PubMed ID: 30571385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study.
    Mongkhon P; Fanning L; Lau WCY; Tse G; Lau KK; Wei L; Kongkaew C; Wong ICK
    Heart Rhythm; 2020 May; 17(5 Pt A):706-713. PubMed ID: 31931172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
    Rahman AA; Michaud J; Dell'Aniello S; Moodie EEM; Brophy JM; Durand M; Guertin JR; Boivin JF; Renoux C
    Neurology; 2023 Mar; 100(12):e1309-e1320. PubMed ID: 36581462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population-Based Cohort Study.
    Hsu JY; Liu PP; Liu AB; Lin SM; Huang HK; Loh CH
    J Am Heart Assoc; 2021 Feb; 10(5):e016437. PubMed ID: 33586465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation.
    Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Curtain C; Salahudeen MS; Peterson GM
    Eur J Clin Invest; 2021 May; 51(5):e13457. PubMed ID: 33222261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database.
    Munir MB; Hlavacek P; Keshishian A; Guo JD; Mallampati R; Ferri M; Russ C; Emir B; Cato M; Yuce H; Hsu JC
    J Interv Card Electrophysiol; 2023 Apr; 66(3):771-782. PubMed ID: 35804258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation.
    Deguchi I; Osada T; Arai N; Takahashi S
    Heart Vessels; 2022 May; 37(5):867-874. PubMed ID: 34797401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020.
    Ko D; Lin KJ; Bessette LG; Lee SB; Walkey AJ; Cheng S; Kim E; Glynn RJ; Kim DH
    JAMA Netw Open; 2022 Nov; 5(11):e2242964. PubMed ID: 36399339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study.
    Halvorsen S; Smith JA; Söderdahl F; Thuresson M; Solli O; Ulvestad M; Jonasson C
    BMC Prim Care; 2022 Aug; 23(1):214. PubMed ID: 36008778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: Results from UK primary care.
    Mongkhon P; Alwafi H; Fanning L; Lau WCY; Wei L; Kongkaew C; Wong ICK
    Br J Clin Pharmacol; 2021 Mar; 87(3):1056-1068. PubMed ID: 32643166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation.
    Chao TF; Chiang CE; Chan YH; Liao JN; Chen TJ; Lip GYH; Chen SA
    Heart Rhythm; 2021 Jun; 18(6):871-877. PubMed ID: 33640447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation.
    Lee SR; Choi EK; Park SH; Jung JH; Han KD; Oh S; Lip GYH
    Stroke; 2021 Nov; 52(11):3459-3468. PubMed ID: 34496627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Outcomes of Treatment With Oral Anticoagulants in Patients With Atrial Fibrillation and Multiple Chronic Conditions: A Comparative Effectiveness Analysis.
    Mentias A; Shantha G; Chaudhury P; Vaughan Sarrazin MS
    JAMA Netw Open; 2018 Sep; 1(5):e182870. PubMed ID: 30646182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.